Havens Advisors’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Havens Advisors’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-251,000	Closed	-$6.05M	–	67
2014 Q2	$6.05M	Buy	+251,000	New	+$2.62M	4.39%	7

Havens Advisors's IDIX Position: Q3 2014 in Review

Havens Advisors sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 251,000 shares — an estimated $6.05M sold.

Havens Advisors first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $6.05M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Havens Advisors reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Havens Advisors sold 251,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $6.05M.
Havens Advisors first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
Havens Advisors's IDENIX PHARMACEUTICALS INC position peaked at $6.05M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Havens Advisors's 13F filing for Q3 2014, filed 31 Oct 2014.